Essai en cours de recrutement = ; Essai en cours = ; Essai terminé = ; Financé par un membre IRDiRC = ; Etude impliquant des membres ERN dans au moins deux états membres =

Essai(s) clinique(s) national(aux)

ESPAGNE

Madrid
ADDRESS: NOT PROVIDED - ES

A Phase 3, Multicenter, Open-label, Long-term, Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects with Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP) - ES

Institution: Information not provided - ES

Plus de détails

ETATS-UNIS

Washington
ADDRESS: NOT PROVIDED - US

Safety and Efficacy of Panhematin™ for Prevention of Acute Attacks of Porphyria

Institution: Information not provided - US

Plus de détails

Essai(s) clinique(s) multinational(aux)

ETATS-UNIS

Massachusetts
CAMBRIDGE

ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic Porphyrias

Alnylam Pharmaceuticals, Inc.

Plus de détails